BeiGene · 13 hours ago
Summer Internship: Distribution & Regional Quality Intern (Remote)
BeOne Medicines USA is a rapidly growing company focused on fighting cancer, offering an internship opportunity for students in the Distribution & Regional Quality department. The role involves supporting quality operations in the pharmaceutical industry, contributing to business-critical projects, and gaining hands-on experience.
BiotechnologyHealthcareLife ScienceHealth CareMedical
Responsibilities
Support standardized complaint investigation templates
Provide support for legacy data in the Global Complaint Mailbox
Support trending of product complaints for Management Review
Quality Agreement administrative updates
Quality record archival
Work with a mentor in the Distribution & Regional Quality North America department
Attend team meetings and all-company events, speaker series, and networking opportunities, as applicable
Work with key stakeholders in and outside of Distribution & Regional Quality department on activities related to the scope of the project assignments
Prepare and present a final presentation for the project assignments
Qualification
Required
Actively enrolled in a university undergraduate, graduate/masters or PhD/PharmD program in a scientific area
Microsoft Office proficiency with Word, Excel, and PowerPoint
Benefits
Medical
Dental
Vision
401(k)
FSA/HSA
Life Insurance
Paid Time Off
Wellness
Company
BeiGene
BeiGene is a global oncology company.
H1B Sponsorship
BeiGene has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (32)
2023 (39)
2022 (40)
2021 (28)
2020 (16)
Funding
Current Stage
Public CompanyTotal Funding
$6.79BKey Investors
Hillhouse InvestmentAmgenCITIC Capital Holdings,Hillhouse Investment
2020-07-12Post Ipo Equity· $2.08B
2019-10-31Post Ipo Equity· $2.7B
2018-08-02Post Ipo Secondary· $903M
Leadership Team
Recent News
2026-01-07
Company data provided by crunchbase